- Home
- ADIL vs SPHL Comparison
ADIL vs SPHL Comparison
Compare ADIL & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADIL | SPHL |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | 73 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 5.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADIL | SPHL |
|---|---|---|
| Price | $2.79 | $2.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | 86.6K | ★ 225.7K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.35 |
| 52 Week High | $5.17 | $25.11 |
Technical Indicators
Market Signals| Indicator | ADIL | SPHL |
|---|---|---|
| Relative Strength Index (RSI) | 55.00 | 44.74 |
| Support Level | $1.59 | $2.47 |
| Resistance Level | $2.98 | $3.01 |
| Average True Range (ATR) | 0.20 | 0.29 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 57.69 | 7.08 |
Price Performance
Historical ComparisonAbout ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.